Skip to main content

Gyne-Lotrimin Inserts Side Effects

Generic name: clotrimazole topical

Medically reviewed by Drugs.com. Last updated on Sep 19, 2023.

Note: This document contains side effect information about clotrimazole topical. Some dosage forms listed on this page may not apply to the brand name Gyne-Lotrimin Inserts.

Applies to clotrimazole topical: topical cream, topical lotion, topical solution.

Serious side effects

Along with its needed effects, clotrimazole topical (the active ingredient contained in Gyne-Lotrimin Inserts) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking clotrimazole topical:

For Healthcare Professionals

Applies to clotrimazole topical: compounding powder, topical cream, topical lotion, topical powder, topical solution, topical spray, vaginal cream with applicator, vaginal kit, vaginal tablet.

Dermatologic

Dermatologic side effects have included erythema, stinging, blistering, peeling, edema, itching, burning, and general skin irritation. Contact dermatitis, confirmed by patch testing, has been documented.[Ref]

Genitourinary

Genitourinary system effects associated with intravaginal use have included burning, itching, cramping, pain, and bleeding. Vulvar lesions and rash have rarely been reported.[Ref]

Frequently asked questions

References

1. Roller JA. Contact allergy to clotrimazole. Br Med J. 1978;2:737.

2. Balato N, Lembo G, Nappa P, Ayala F. Contact dermatitis from clotrimazole. Contact Dermatitis. 1985;12:110.

3. Kalb RE, Grossman ME. Contact dermatitis to clotrimazole. Cutis. 1985;36:240-2.

4. Product Information. Mycelex (clotrimazole). Bayer. 2001;PROD.

5. Baes H. Contact dermatitis from clotrimazole. Contact Dermatitis. 1995;32:187-8.

6. Lebherz T, Guess E, Wolfson N. Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152:965-8.

7. Wolfson N, Riley J, Samuels B, Singh JM. Clinical toxicology of clotrimazole when administered vaginally. Clin Toxicol. 1981;18:41-5.

8. Pons V, Greenspan D, Debruin M. Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group. J Acquir Immune Defic Syndr. 1993;6:1311-6.

9. Brown D Jr, Binder GL, Gardner HL, Wells J. Comparison of econazole and clotrimazole in the treatment of vulvovaginal candidiasis. Obstet Gynecol. 1980;56:121-3.

10. Lebherz TB, Ford LC, Kleinkopf V. A comparison of a three-day and seven-day clotrimazole regimen for vulvovaginal candidiasis. Clin Ther. 1981;3:344-8.

11. Stein GE, Christensen S, Mummaw N. Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis. DICP. 1991;25:582-5.

12. Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery. Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs. 1975;9:424-47.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.